• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估人工智能模型预测未来乳腺癌风险的研究

Evaluation of an AI Model to Assess Future Breast Cancer Risk.

机构信息

From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.).

出版信息

Radiology. 2023 Jun;307(5):e222679. doi: 10.1148/radiol.222679.

DOI:10.1148/radiol.222679
PMID:37310244
Abstract

Background Accurate breast cancer risk assessment after a negative screening result could enable better strategies for early detection. Purpose To evaluate a deep learning algorithm for risk assessment based on digital mammograms. Materials and Methods A retrospective observational matched case-control study was designed using the OPTIMAM Mammography Image Database from the National Health Service Breast Screening Programme in the United Kingdom from February 2010 to September 2019. Patients with breast cancer (cases) were diagnosed following a mammographic screening or between two triannual screening rounds. Controls were matched based on mammography device, screening site, and age. The artificial intelligence (AI) model only used mammograms at screening before diagnosis. The primary objective was to assess model performance, with a secondary objective to assess heterogeneity and calibration slope. The area under the receiver operating characteristic curve (AUC) was estimated for 3-year risk. Heterogeneity according to cancer subtype was assessed using a likelihood ratio interaction test. Statistical significance was set at < .05. Results Analysis included patients with screen-detected (median age, 60 years [IQR, 55-65 years]; 2044 female, including 1528 with invasive cancer and 503 with ductal carcinoma in situ [DCIS]) or interval (median age, 59 years [IQR, 53-65 years]; 696 female, including 636 with invasive cancer and 54 with DCIS) breast cancer and 1:1 matched controls, each with a complete set of mammograms at the screening preceding diagnosis. The AI model had an overall AUC of 0.68 (95% CI: 0.66, 0.70), with no evidence of a significant difference between interval and screen-detected (AUC, 0.69 vs 0.67; = .085) cancer. The calibration slope was 1.13 (95% CI: 1.01, 1.26). There was similar performance for the detection of invasive cancer versus DCIS (AUC, 0.68 vs 0.66; = .057). The model had higher performance for advanced cancer risk (AUC, 0.72 ≥stage II vs 0.66 <stage II; = .037). The AUC for detecting breast cancer in mammograms at diagnosis was 0.89 (95% CI: 0.88, 0.91). Conclusion The AI model was found to be a strong predictor of breast cancer risk for 3-6 years following a negative mammographic screening. © RSNA, 2023 . See also the editorial by Mann and Sechopoulos in this issue.

摘要

背景

在阴性筛查结果后进行准确的乳腺癌风险评估可以为早期检测制定更好的策略。目的:评估基于数字乳房 X 线照片的深度学习算法进行风险评估。材料和方法:本研究采用英国国家卫生服务乳房筛查计划 2010 年 2 月至 2019 年 9 月期间的 OPTIMAM 乳房 X 线图像数据库进行回顾性观察性匹配病例对照研究。乳腺癌患者(病例)在乳房 X 线筛查后或两次三年筛查期间被诊断出。对照组根据乳房 X 线摄影设备、筛查地点和年龄进行匹配。人工智能(AI)模型仅使用诊断前筛查的乳房 X 线照片。主要目的是评估模型性能,次要目的是评估异质性和校准斜率。接受者操作特征曲线(ROC)下的面积(AUC)用于估计 3 年风险。使用似然比交互检验评估癌症亚型的异质性。统计显著性设定为 <.05。结果:分析包括了经筛检(中位年龄 60 岁[IQR,55-65 岁];2044 名女性,包括 1528 名浸润性癌症和 503 名导管原位癌[DCIS])或间隔(中位年龄 59 岁[IQR,53-65 岁];696 名女性,包括 636 名浸润性癌症和 54 名 DCIS)乳腺癌患者和 1:1 匹配的对照组,每组在诊断前的筛查中均有完整的一套乳房 X 线照片。AI 模型的总体 AUC 为 0.68(95%CI:0.66,0.70),间隔和经筛检癌症之间没有证据表明存在显著差异(AUC,0.69 比 0.67; =.085)。校准斜率为 1.13(95%CI:1.01,1.26)。检测浸润性癌症与 DCIS 的性能相似(AUC,0.68 比 0.66; =.057)。对于高级癌症风险,该模型的性能更高(AUC,0.72≥II 期比 0.66<II 期; =.037)。在诊断时的乳房 X 线照片中检测乳腺癌的 AUC 为 0.89(95%CI:0.88,0.91)。结论:该 AI 模型被发现是阴性乳房 X 线筛查后 3-6 年内乳腺癌风险的有力预测因子。©RSNA,2023。也可参见本期 Mann 和 Sechopoulos 的社论。

相似文献

1
Evaluation of an AI Model to Assess Future Breast Cancer Risk.评估人工智能模型预测未来乳腺癌风险的研究
Radiology. 2023 Jun;307(5):e222679. doi: 10.1148/radiol.222679.
2
Are better AI algorithms for breast cancer detection also better at predicting risk? A paired case-control study.用于乳腺癌检测的人工智能算法是否也能更好地预测风险?一项配对病例对照研究。
Breast Cancer Res. 2024 Feb 7;26(1):25. doi: 10.1186/s13058-024-01775-z.
3
External Testing of a Commercial AI Algorithm for Breast Cancer Detection at Screening Mammography.用于筛查乳腺钼靶摄影中乳腺癌检测的商用人工智能算法的外部测试
Radiol Artif Intell. 2025 May;7(3):e240287. doi: 10.1148/ryai.240287.
4
Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway.基于挪威乳腺筛查项目的筛查性乳腺钼靶 X 光片评估乳腺癌检测人工智能系统的性能。
Radiol Artif Intell. 2024 May;6(3):e230375. doi: 10.1148/ryai.230375.
5
Deep Learning for Breast Cancer Risk Prediction: Application to a Large Representative UK Screening Cohort.深度学习在乳腺癌风险预测中的应用:对一个大型有代表性的英国筛查队列的应用。
Radiol Artif Intell. 2024 Jul;6(4):e230431. doi: 10.1148/ryai.230431.
6
Accuracy of an Artificial Intelligence System for Interval Breast Cancer Detection at Screening Mammography.人工智能系统在筛查性乳房 X 光摄影中检测间期乳腺癌的准确性。
Radiology. 2024 Aug;312(2):e232303. doi: 10.1148/radiol.232303.
7
Performance of Two Deep Learning-based AI Models for Breast Cancer Detection and Localization on Screening Mammograms from BreastScreen Norway.基于深度学习的两种人工智能模型在挪威乳腺癌筛查乳房X光片上进行乳腺癌检测和定位的性能
Radiol Artif Intell. 2025 May;7(3):e240039. doi: 10.1148/ryai.240039.
8
Assessing Breast Cancer Risk by Combining AI for Lesion Detection and Mammographic Texture.利用人工智能进行病灶检测和乳腺纹理分析来评估乳腺癌风险。
Radiology. 2023 Aug;308(2):e230227. doi: 10.1148/radiol.230227.
9
Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.按筛查频率计算的累计 6 年筛检性导管原位癌风险。
JAMA Netw Open. 2023 Feb 1;6(2):e230166. doi: 10.1001/jamanetworkopen.2023.0166.
10
Use of an AI Score Combining Cancer Signs, Masking, and Risk to Select Patients for Supplemental Breast Cancer Screening.利用 AI 评分综合癌症征象、伪装和风险来选择需要补充乳腺癌筛查的患者。
Radiology. 2024 Apr;311(1):e232535. doi: 10.1148/radiol.232535.

引用本文的文献

1
Artificial Intelligence-Driven Personalization in Breast Cancer Screening: From Population Models to Individualized Protocols.乳腺癌筛查中人工智能驱动的个性化:从群体模型到个性化方案
Cancers (Basel). 2025 Sep 4;17(17):2901. doi: 10.3390/cancers17172901.
2
Deep learning mammography-based breast cancer risk model, its serial change, and breast cancer mortality.基于深度学习乳腺X线摄影的乳腺癌风险模型、其系列变化及乳腺癌死亡率。
Breast Cancer. 2025 Sep 3. doi: 10.1007/s12282-025-01772-w.
3
AI-CAD-Guided Mammographic Assessment of Tumor Size and T Stage: Concordance with MRI for Clinical Staging in Breast Cancer Patients Considered for NAC.
人工智能计算机辅助检测引导下对肿瘤大小和T分期的乳腺钼靶评估:与MRI在考虑接受新辅助化疗的乳腺癌患者临床分期中的一致性
Tomography. 2025 Jun 24;11(7):72. doi: 10.3390/tomography11070072.
4
Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis.女性乳腺癌发病风险预测模型的开发与性能:一项系统评价和荟萃分析。
Ann Med. 2025 Dec;57(1):2534522. doi: 10.1080/07853890.2025.2534522. Epub 2025 Jul 20.
5
Exploring Opportunities and Challenges of AI in Primary Healthcare: A Qualitative Study with Family Doctors in Lithuania.探索人工智能在基层医疗保健中的机遇与挑战:对立陶宛家庭医生的定性研究
Healthcare (Basel). 2025 Jun 14;13(12):1429. doi: 10.3390/healthcare13121429.
6
Mammographic calcifications association with risk of advanced breast cancer.乳腺钼靶钙化与晚期乳腺癌风险的关联
Breast Cancer Res Treat. 2025 Aug;212(3):555-567. doi: 10.1007/s10549-025-07753-z. Epub 2025 Jun 17.
7
Artificial Intelligence and Breast Cancer Management: From Data to the Clinic.人工智能与乳腺癌管理:从数据到临床
Cancer Innov. 2025 Feb 20;4(2):e159. doi: 10.1002/cai2.159. eCollection 2025 Apr.
8
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection.人工智能算法用于早期乳腺癌检测。
JAMA Netw Open. 2024 Oct 1;7(10):e2437402. doi: 10.1001/jamanetworkopen.2024.37402.
9
Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening.人工智能在风险分层乳腺癌筛查中的成本效益。
JAMA Netw Open. 2024 Sep 3;7(9):e2431715. doi: 10.1001/jamanetworkopen.2024.31715.
10
Deep Learning for Breast Cancer Risk Prediction: Application to a Large Representative UK Screening Cohort.深度学习在乳腺癌风险预测中的应用:对一个大型有代表性的英国筛查队列的应用。
Radiol Artif Intell. 2024 Jul;6(4):e230431. doi: 10.1148/ryai.230431.